Risk to Benefit Ratio: when is a drug too risky to stay on the market?

Pundits have said it takes at least 100 deaths for the FDA to act regarding pulling a prescription drug from the marketplace. The playing field is far from level for risky medications versus the risks of supplements including herbs. It is of little comfort to consumers that the FDA has no written guidelines for deciding… Continue reading Risk to Benefit Ratio: when is a drug too risky to stay on the market?

Supplements Still in Peril

Over the past year, we fought four different Congressional bills that would have affected your access to supplements. In our Action Alert, we need your help to educate our lawmakers, most of whom know little or nothing about existing supplement regulation or why supplements are not drugs.